25 insiders reported 110 Form 4 transactions for LEXICON PHARMACEUTICALS, INC. (LXRX) over the past 18 months (most recent 2026-05-08). Recent activity: Artal Group S.A. (Director) Buy 20.4M shares, Artal International S.C.A. (Director) Buy 20.4M shares, Westend S.A. (Director) Buy 20.4M shares, Stichting Administratiekantoor Westend (Director) Buy 20.4M shares, Artal International Management S.A. (Director) Buy 20.4M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | Artal Group S.A. | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Artal International S.C.A. | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Westend S.A. | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Stichting Administratiekantoor Westend | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Artal International Management S.A. | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Wittouck Amaury | Director | Buy | 20.4M | $0 |
| 2026-05-08 | Artal Participations S.a r.l. | Director | Buy | 20.4M | $0 |
| 2026-03-03 | DeFrancesco Lisa | SVP, IR and Corp Comm | Buy | 128,190 | $0 |
| 2026-03-03 | Gopinathan Suma | SVP, Discovery | Buy | 20,310 | $0 |
| 2026-03-03 | Gopinathan Suma | SVP, Discovery | Buy | 65,640 | $0 |
| 2026-03-03 | Gopinathan Suma | SVP, Discovery | Sell | 24,338 | $35,777 |
| 2026-03-03 | Coiante Scott M | SVP, Chief Financial Officer | Buy | 160,237 | $0 |
| 2026-03-03 | Coiante Scott M | SVP, Chief Financial Officer | Sell | 54,881 | $80,675 |
| 2026-03-03 | Crum Brian T | SVP, General Counsel & Secr. | Buy | 33,457 | $0 |
| 2026-03-03 | Crum Brian T | SVP, General Counsel & Secr. | Buy | 69,386 | $0 |
| 2026-03-03 | Crum Brian T | SVP, General Counsel & Secr. | Buy | 170,163 | $0 |
| 2026-03-03 | Crum Brian T | SVP, General Counsel & Secr. | Sell | 105,019 | $154,378 |
| 2026-03-03 | DeFrancesco Lisa | SVP, IR and Corp Comm | Buy | 24,674 | $0 |
| 2026-03-03 | Gopinathan Suma | SVP, Discovery | Buy | 14,000 | $0 |
| 2026-03-03 | DeFrancesco Lisa | SVP, IR and Corp Comm | Sell | 74,572 | $109,621 |
| 2026-03-03 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Buy | 67,090 | $0 |
| 2026-03-03 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Sell | 35,826 | $52,664 |
| 2026-03-03 | Exton Michael | Chief Executive Officer | Buy | 503,263 | $0 |
| 2026-03-03 | Exton Michael | Chief Executive Officer | Sell | 204,831 | $301,102 |
| 2026-03-03 | McDermott Wendy | SVP, Human Resources | Buy | 27,697 | $0 |
Source: SEC Form 4 filings · as of 2026-05-08